Mariner’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $36.9M | Buy |
241,552
+5,076
| +2% | +$778K | 0.04% | 324 |
|
|
2025
Q4 | $32.6M | Buy |
236,476
+1,586
| +0.7% | +$208K | 0.04% | 329 |
|
|
2025
Q3 | $30.1M | Buy |
234,890
+7,519
| +3% | +$917K | 0.04% | 336 |
|
|
2025
Q2 | $27.5M | Buy |
227,371
+11,375
| +5% | +$1.28M | 0.04% | 341 |
|
|
2025
Q1 | $24.1M | Sell |
215,996
-19,222
| -8% | -$2.05M | 0.04% | 347 |
|
|
2024
Q4 | $22.9M | Buy |
235,218
+32,170
| +16% | +$3.43M | 0.04% | 345 |
|
|
2024
Q3 | $23.4M | Buy |
203,048
+5,267
| +3% | +$598K | 0.04% | 331 |
|
|
2024
Q2 | $21.1M | Buy |
197,781
+5,359
| +3% | +$538K | 0.04% | 328 |
|
|
2024
Q1 | $18.6M | Buy |
192,422
+820
| +0.4% | +$84.1K | 0.04% | 341 |
|
|
2023
Q4 | $19.3M | Buy |
191,602
+1,855
| +1% | +$179K | 0.05% | 313 |
|
|
2023
Q3 | $19.3M | Buy |
189,747
+3,694
| +2% | +$375K | 0.05% | 290 |
|
|
2023
Q2 | $18.8M | Sell |
186,053
-5,052
| -3% | -$505K | 0.05% | 299 |
|
|
2023
Q1 | $17.6M | Sell |
191,105
-2,819
| -1% | -$246K | 0.05% | 314 |
|
|
2022
Q4 | $17.6M | Buy |
193,924
+1,548
| +0.8% | +$130K | 0.06% | 300 |
|
|
2022
Q3 | $14.6M | Buy |
192,376
+31,377
| +19% | +$2.6M | 0.06% | 281 |
|
|
2022
Q2 | $13.6M | Buy |
160,999
+4,936
| +3% | +$433K | 0.06% | 280 |
|
|
2022
Q1 | $13.7M | Buy |
156,063
+4,463
| +3% | +$386K | 0.05% | 287 |
|
|
2021
Q4 | $13.3M | Buy |
151,600
+24,750
| +20% | +$2.05M | 0.06% | 267 |
|
|
2021
Q3 | $10.4M | Buy |
126,850
+74,123
| +141% | +$6.67M | 0.05% | 274 |
|
|
2021
Q2 | $4.81M | Buy |
52,727
+3,038
| +6% | +$271K | 0.03% | 335 |
|
|
2021
Q1 | $4.25M | Buy |
49,689
+4,543
| +10% | +$408K | 0.03% | 331 |
|
|
2020
Q4 | $4.26M | Buy |
45,146
+8,527
| +23% | +$745K | 0.03% | 308 |
|
|
2020
Q3 | $3.18M | Sell |
36,619
-1,302
| -3% | -$113K | 0.03% | 311 |
|
|
2020
Q2 | $3.31M | Buy |
37,921
+3,044
| +9% | +$263K | 0.03% | 314 |
|
|
2020
Q1 | $2.88M | Buy |
34,877
+7,489
| +27% | +$668K | 0.04% | 309 |
|
|
2019
Q4 | $2.59M | Sell |
27,388
-746
| -3% | -$66.9K | 0.03% | 357 |
|
|
2019
Q3 | $2.44M | Buy |
28,134
+2,601
| +10% | +$234K | 0.03% | 341 |
|
|
2019
Q2 | $2.33M | Buy |
25,533
+2,056
| +9% | +$174K | 0.03% | 364 |
|
|
2019
Q1 | $2.02M | Buy |
23,477
+8,173
| +53% | +$656K | 0.03% | 376 |
|
|
2018
Q4 | $1.18M | Sell |
15,304
-208
| -1% | -$16.2K | 0.02% | 403 |
|
|
2018
Q3 | $1.2M | Buy |
15,512
+3,199
| +26% | +$236K | 0.03% | 370 |
|
|
2018
Q2 | $833K | Buy |
12,313
+5,938
| +93% | +$410K | 0.02% | 438 |
|
|
2018
Q1 | $462K | Buy |
+6,375
| New | +$485K | 0.02% | 452 |
|
|
2017
Q4 | – | Sell |
-3,481
| Closed | -$268K | – | 591 |
|
|
2017
Q3 | $268K | Buy |
+3,481
| New | +$263K | 0.01% | 425 |
|
|
2017
Q2 | – | Sell |
-5,025
| Closed | -$334K | – | 545 |
|
|
2017
Q1 | $334K | Buy |
5,025
+129
| +3% | +$8.6K | 0.01% | 446 |
|
|
2016
Q4 | $320K | Buy |
4,896
+655
| +15% | +$42.5K | 0.01% | 430 |
|
|
2016
Q3 | $301K | Buy |
+4,241
| New | +$309K | 0.01% | 475 |
|
Other funds holding NVS
Mariner's NVS Position: Q1 2026 in Review
Mariner increased its Novartis (NVS) stake by 2.1% in Q1 2026, buying an estimated $778K and bringing the position to 241,552 shares worth $36.9M. The position accounts for 0.04% of the portfolio, ranked #324.
Mariner first reported a position in NVS in Q3 2016 and has held it in 37 quarters since. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Mariner held 241,552 shares of Novartis worth $36.9M as of Q1 2026.
- Mariner bought 5,076 Novartis shares in Q1 2026, an estimated $778K.
- Novartis made up 0.04% of Mariner's portfolio in Q1 2026, its #324 holding.
- Mariner first reported a position in Novartis in Q3 2016 and has held it in 37 quarters since.
- 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.